CN Bio, announced the launch of its PhysioMimix® DILI assay kit: Human 24. Built upon CN Bio’s human-derived and highly characterized liver microphysiological system (MPS).

Eppendorf and the journal Science are now accepting applications for the 2025 Eppendorf & Science Prize for Neurobiology.

MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a cell-engineering focused company announced the acquisition of SeQure Dx.

Ncardia, announced the launch of Ncyte® Heart in a Box, a breakthrough 3D cardiac microtissue model designed to drive innovation in cardiovascular research and drug discovery.

MIMETAS, has launched OrganoPlate UniFlow (UF), the first commercially available unidirectional, gravity-driven pumpless flow system for drug discovery and disease research.

Revvity, Inc. is set to unveil its new Phenologic.AI™ software at SLAS2025 in San Diego, January 27-29.

bit.bio, announces the launch of its ioTracker Cells range, starting with GFP ioMicroglia, a progressive tool designed to accelerate complex neurodegenerative disease research and drug discovery.

Researchers invited to gain early access to next-generation platform to optimize functional single-cell analysis workflows across expanded applications in life science R&D.

Inventia Life Science, announces the launch of RASTRUM™ Allegro, an advancement in 3D cell culture technology designed to accelerate drug discovery and disease research with unprecedented scalability, reproducibility and efficiency.

Curiox Biosystems, is pleased to announce the launch of the Pluto ALPHA, the latest addition to the Pluto line of products. This compact and intuitive device redefines cell washing automation.